BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
McKinsey
Moodys
Federal Trade Commission
Healthtrust
Express Scripts
Dow
Cerilliant
Fuji
US Army

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,420,639

« Back to Dashboard

Summary for Patent: 4,420,639
Title: Aromatic compounds
Abstract:4-(6'-Methoxy-2'-naphthyl) butan-2-one is described as having anti-inflammatory activity and an improved therapeutic ratio.
Inventor(s): Lake; Anthony W. (Guildford Surrey, GB2), Rose; Carl J. (London, GB2)
Assignee: Beecham Group Limited (GB2)
Application Number:06/320,190
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,420,639

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,420,639

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom42550/73Sep 11, 1973

International Patents Family Members for US Patent 4,420,639

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 7313674 ➤ Subscribe
Belgium 819794 ➤ Subscribe
Switzerland 599090 ➤ Subscribe
Switzerland 603523 ➤ Subscribe
Switzerland 603524 ➤ Subscribe
Switzerland 603525 ➤ Subscribe
Switzerland 603526 ➤ Subscribe
Switzerland 603527 ➤ Subscribe
Switzerland 603543 ➤ Subscribe
Switzerland 613932 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Citi
Federal Trade Commission
Dow
Deloitte
Fish and Richardson
UBS
Accenture
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot